Palladyne AI Corp.(PDYN)

Search documents
Palladyne AI Corp.(PDYN) - 2023 Q4 - Annual Report
2024-02-28 21:35
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-39897 SARCOS TECHNOLOGY AND ROBOTICS CORPORATION (Exact name of registrant as specified in its charter) Delaware 85-2838301 (State or ...
Palladyne AI Corp.(PDYN) - 2023 Q3 - Quarterly Report
2023-11-14 21:23
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 Title of each class Trading Symbol(s) Name of each exchange on which registered FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______ to _______ Commission File Number: 001-39897 SARCOS TECHNOLOGY AND R ...
Palladyne AI Corp.(PDYN) - 2023 Q2 - Quarterly Report
2023-08-09 20:21
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 Title of each class Trading Symbol(s) Name of each exchange on which registered FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______ to _______ Commission File Number: 001-39897 SARCOS TECHNOLOGY AND ROBOTI ...
Palladyne AI Corp.(PDYN) - 2023 Q1 - Quarterly Report
2023-05-10 20:26
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 Title of each class Trading Symbol(s) Name of each exchange on which registered FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______ to _______ Commission File Number: 001-39897 SARCOS TECHNOLOGY AND ROBOT ...
Palladyne AI Corp.(PDYN) - 2022 Q4 - Annual Report
2023-03-16 20:32
Financial Performance - The company incurred a net loss of $157.1 million for the year ended December 31, 2022, compared to a net loss of $81.5 million for the year ended December 31, 2021, and expects to continue incurring losses until at least 2025[160]. - Negative cash flow from operating activities was $65.4 million for the year ended December 31, 2022, and $42.1 million for the year ended December 31, 2021, with expectations of continued negative cash flow until 2025[164]. - The company has not yet achieved positive operating cash flow, and its ability to generate such cash flow remains uncertain[163]. - The company does not expect to achieve positive operating cash flows until at least 2025, necessitating additional financing for ongoing operations[192]. - The company may not achieve profitability in the near future, as it continues to generate taxable losses[300]. Product Development and Commercialization - The company began production of the initial commercial version of the Guardian XM in September 2022 and the Guardian XT in December 2022, with expected customer deliveries starting in the first half of 2023[175]. - Production of the Guardian Sea Class is expected to begin in the second half of 2023, with deliveries anticipated in the same timeframe[175]. - The company anticipates delays in the commercialization of core systems, which could postpone initial deliveries and revenue recognition[186]. - The company has limited experience in large-scale commercialization of robotic systems, which may hinder effective market penetration[190]. - The company anticipates significant additional product development efforts and expenses, with ongoing challenges in commercializing core and future products[211]. - The company may face delays in product development phases, which could postpone customer testing and lead to missed sales opportunities[213]. Supply Chain and Operational Challenges - The company has faced supply chain challenges, including increased costs and interruptions in the supply of components, which could delay product development and commercialization[176]. - The company is dependent on suppliers, some of which are sole or limited source suppliers, and any inability to secure necessary components could adversely affect its business[181]. - The company relies on third-party suppliers for key components, which may affect sales, revenue, and profitability if supply issues arise[182]. - The company has limited negotiating leverage with suppliers, potentially leading to unfavorable pricing and terms[183]. - Significant increases in material costs and supply chain disruptions are currently impacting the company, particularly in securing components for product development[184]. - The company is experiencing disruptions and delays in its supply chain, which could materially affect its business and financial condition[242]. Human Resources and Management - The company continues to experience challenges in hiring qualified personnel, which could impact product development and commercialization timelines[179]. - The ongoing COVID-19 pandemic has adversely impacted the company's ability to recruit skilled employees and meet product development timelines[242]. - The company faces risks related to hiring and retaining qualified employees, which could harm its ability to compete and operate effectively[236]. - The management team has limited experience in operating a publicly-traded company, which may affect its ability to manage regulatory obligations[238]. Legal and Regulatory Compliance - The company incurs significant legal and accounting expenses as a publicly-traded entity, which could adversely impact its financial condition[240]. - The company may face litigation risks related to past accounting issues and the potential for future material weaknesses in financial reporting[287]. - The California Consumer Privacy Act (CCPA) and other state laws may increase compliance costs and potential liabilities as the company expands operations[311]. - Compliance with evolving data privacy laws, such as the GDPR, may result in substantial costs and necessitate changes to business practices[312]. - The company is subject to audits and investigations by government agencies, which could divert resources and impact operations[326]. Strategic Initiatives and Market Position - The acquisition of RE2, completed in April 2022, is expected to enhance the company's product portfolio and market reach, although integration risks remain[169]. - The company plans to expand its production capabilities and sales infrastructure, which will require significant investment and may lead to increased operational costs[161]. - The company is shifting to a standard product sales model for its robotic systems, reducing capital requirements and improving manufacturing efficiency[207]. - The company targets large multinational businesses as customers, which have substantial negotiating power and may develop competitive internal solutions[265]. - The competitive landscape includes established companies like ABB Robotics and Honeywell, which could pose significant challenges[269]. Financial Risks and Capital Needs - Future capital needs may require the company to seek additional financing, potentially diluting stockholder equity[191]. - The company has recorded a full valuation allowance related to net operating loss carryforwards due to uncertainty in realizing future benefits[304]. - Significant capital is required for business development, including R&D, production, and marketing, leading to ongoing high expenses that may impact profitability[258]. - The company may face challenges in developing production processes within projected costs and timelines, which could adversely affect its business prospects[252]. Cybersecurity and Data Protection - The company faces increasing cybersecurity risks due to remote work and geopolitical tensions, particularly related to the war in Ukraine[315]. - The company has implemented security measures to protect data, but these cannot guarantee complete security against breaches[320]. - The company may incur significant costs related to privacy and security breaches, impacting its financial condition[322]. Environmental and Compliance Risks - Environmental costs and regulations related to climate change could adversely affect future earnings and product affordability[345]. - Future climate change regulations may lead to increased direct compliance costs and indirect costs from suppliers and customers, potentially decreasing demand for products[347]. - Compliance with export control laws is critical, as non-compliance could lead to severe penalties and affect revenue generation[333].
Palladyne AI Corp.(PDYN) - 2022 Q2 - Quarterly Report
2022-08-09 21:27
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______ to _______ Commission File Number: 001-39897 SARCOS TECHNOLOGY AND ROBOTICS CORPORATION (Exact Name of Registrant as Specified in its Charter) Delaware 8 ...
Palladyne AI Corp.(PDYN) - 2022 Q1 - Quarterly Report
2022-05-11 20:12
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______ to _______ Commission File Number: 001-39897 SARCOS TECHNOLOGY AND ROBOTICS CORPORATION (Exact Name of Registrant as Specified in its Charter) Delaware ...
Palladyne AI Corp.(PDYN) - 2021 Q4 - Annual Report
2022-03-29 20:21
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) (I.R.S. Employer Identification No.) 650 South 500 West, Suite 150 Salt Lake City, Utah, 84101 (Address of principal executive offices) (888) 927-7296 ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commissio ...
Palladyne AI Corp.(PDYN) - 2021 Q3 - Quarterly Report
2021-11-09 21:45
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______ to _______ Commission File Number: 001-39897 SARCOS TECHNOLOGY AND ROBOTICS CORPORATION (Exact Name of Registrant as Specified in its Charter) Delaw ...
Palladyne AI Corp.(PDYN) - 2021 Q2 - Quarterly Report
2021-08-16 20:01
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended June 30, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-39897 ROTOR ACQUISITION CORP. (Exact Name of Registrant as Specified in Its Charter) Delaware 85-2838301 (State or other jurisdiction of incorporation ...